Analysts See $0.34 EPS for Boston Scientific (BSX); Campbell Soup Company (CPB) Shorts Decreased By 3.79%

January 18, 2018 - By Maria Brooks

Campbell Soup Company (NYSE:CPB) had a decrease of 3.79% in short interest. CPB’s SI was 22.46 million shares in January as released by FINRA. Its down 3.79% from 23.34 million shares previously. With 4.09 million avg volume, 6 days are for Campbell Soup Company (NYSE:CPB)’s short sellers to cover CPB’s short positions. The SI to Campbell Soup Company’s float is 11.86%. The stock increased 1.12% or $0.52 during the last trading session, reaching $46.96. About 2.02M shares traded. Campbell Soup Company (NYSE:CPB) has declined 12.82% since January 18, 2017 and is downtrending. It has underperformed by 29.52% the S&P500.

Analysts expect Boston Scientific Corporation (NYSE:BSX) to report $0.34 EPS on February, 1.They anticipate $0.04 EPS change or 13.33% from last quarter’s $0.3 EPS. BSX’s profit would be $466.89 million giving it 20.04 P/E if the $0.34 EPS is correct. After having $0.31 EPS previously, Boston Scientific Corporation’s analysts see 9.68% EPS growth. The stock increased 1.00% or $0.27 during the last trading session, reaching $27.25. About 5.86 million shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since January 18, 2017 and is uptrending. It has outperformed by 2.42% the S&P500.

Among 29 analysts covering Boston Scientific Corporation (NYSE:BSX), 23 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. Boston Scientific Corporation had 84 analyst reports since July 27, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Friday, July 29 by Jefferies. The stock has “Hold” rating by BTIG Research on Monday, June 26. The firm has “Buy” rating given on Friday, December 1 by SunTrust. Citigroup maintained the stock with “Buy” rating in Thursday, October 6 report. The rating was maintained by Needham with “Buy” on Friday, April 28. Nomura initiated Boston Scientific Corporation (NYSE:BSX) on Thursday, March 17 with “Buy” rating. The firm earned “Buy” rating on Thursday, August 31 by Needham. Needham maintained the shares of BSX in report on Friday, February 3 with “Buy” rating. Needham maintained the stock with “Buy” rating in Wednesday, October 28 report. The firm earned “Buy” rating on Thursday, July 23 by Benchmark.

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.01, from 1.03 in 2017Q2. It increased, as 33 investors sold Boston Scientific Corporation shares while 166 reduced holdings. 43 funds opened positions while 164 raised stakes. 1.21 billion shares or 1.08% less from 1.22 billion shares in 2017Q2 were reported. Geller Family Office Limited has invested 39.41% in Boston Scientific Corporation (NYSE:BSX). Moreover, X Mngmt Co Ltd Liability Company has 0.02% invested in Boston Scientific Corporation (NYSE:BSX) for 27,856 shares. Qs Investors Limited Liability owns 0.01% invested in Boston Scientific Corporation (NYSE:BSX) for 56,332 shares. Braun Stacey Associates, New York-based fund reported 622,295 shares. Nordea Mngmt invested 0.01% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Fifth Third Bancshares holds 8,413 shares or 0% of its portfolio. California-based Checchi Cap Advisers Limited Liability Co has invested 0.03% in Boston Scientific Corporation (NYSE:BSX). 1.27M are held by Retirement Of Alabama. 9,122 were accumulated by Prudential Public Ltd Liability. State Of New Jersey Common Pension Fund D invested in 490,000 shares. Pictet Asset Mgmt Ltd owns 1.23M shares for 0.1% of their portfolio. Lord Abbett & Llc has invested 0.14% in Boston Scientific Corporation (NYSE:BSX). Great West Life Assurance Can owns 991,691 shares for 0.07% of their portfolio. Meiji Yasuda Asset Management has invested 0.15% in Boston Scientific Corporation (NYSE:BSX). Vantage Lc stated it has 0.04% in Boston Scientific Corporation (NYSE:BSX).

Boston Scientific Corporation develops, makes, and markets medical devices for use in various interventional medical specialties worldwide. The company has market cap of $37.42 billion. It operates through three divisions: Cardiovascular, Rhythm Management, and MedSurg. It has a 44.67 P/E ratio. The firm offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems.

Since August 1, 2017, it had 0 insider purchases, and 13 sales for $15.16 million activity. Phalen Michael P. sold $440,547 worth of stock. Another trade for 8,763 shares valued at $243,074 was sold by Pierce David A. $323,435 worth of Boston Scientific Corporation (NYSE:BSX) shares were sold by Pratt Timothy A.. Carruthers Wendy had sold 12,433 shares worth $332,584 on Thursday, August 3. Shares for $10.11M were sold by Bose Supratim on Tuesday, October 3. 57,031 shares were sold by Nanavaty Maulik, worth $1.56 million on Wednesday, August 30. $208,328 worth of Boston Scientific Corporation (NYSE:BSX) was sold by Sorenson John Bradley.

Campbell Soup Company, together with its subsidiaries, makes and markets food and beverage products. The company has market cap of $14.11 billion. It operates through three divisions: Americas Simple Meals and Beverages; Global Biscuits and Snacks; and Campbell Fresh. It has a 16.45 P/E ratio. The Americas Simple Meals and Beverages segment engages in the retail and food service of CampbellÂ’s condensed and ready-to-serve soups; Swanson broth and stocks; Prego pasta sauces; Pace Mexican sauces; CampbellÂ’s gravies, pastas, beans, and dinner sauces; Swanson canned poultry; Plum food and snacks; V8 juices and beverages; and CampbellÂ’s tomato juices.

Among 16 analysts covering Campbell Soup (NYSE:CPB), 2 have Buy rating, 6 Sell and 8 Hold. Therefore 13% are positive. Campbell Soup had 53 analyst reports since July 23, 2015 according to SRatingsIntel. On Friday, August 26 the stock rating was maintained by Deutsche Bank with “Hold”. As per Thursday, November 23, the company rating was maintained by UBS. As per Wednesday, October 25, the company rating was maintained by RBC Capital Markets. JP Morgan upgraded the shares of CPB in report on Tuesday, January 19 to “Overweight” rating. The firm has “Hold” rating by Piper Jaffray given on Tuesday, July 18. The firm earned “Sell” rating on Thursday, November 9 by UBS. UBS maintained Campbell Soup Company (NYSE:CPB) on Friday, September 2 with “Sell” rating. The firm earned “Sector Perform” rating on Friday, September 1 by RBC Capital Markets. Barclays Capital downgraded the stock to “Underweight” rating in Friday, January 15 report. Piper Jaffray maintained Campbell Soup Company (NYSE:CPB) on Monday, November 27 with “Hold” rating.

Investors sentiment decreased to 0.98 in Q3 2017. Its down 0.01, from 0.99 in 2017Q2. It turned negative, as 49 investors sold Campbell Soup Company shares while 153 reduced holdings. 49 funds opened positions while 148 raised stakes. 137.50 million shares or 3.69% more from 132.61 million shares in 2017Q2 were reported. First Personal Fin holds 0.03% or 2,677 shares in its portfolio. 33,625 are owned by Retail Bank Of Nova Scotia. Texas Permanent School Fund invested 0.03% of its portfolio in Campbell Soup Company (NYSE:CPB). Department Mb Savings Bank N A invested in 1,300 shares. Fjarde Ap holds 0.03% of its portfolio in Campbell Soup Company (NYSE:CPB) for 33,555 shares. New York-based Gabelli Funds Llc has invested 0.12% in Campbell Soup Company (NYSE:CPB). Two Sigma Secs Ltd Liability Corporation has invested 0.03% in Campbell Soup Company (NYSE:CPB). Envestnet Asset Management Inc stated it has 8,529 shares. Moreover, Cibc Mkts Corporation has 0.01% invested in Campbell Soup Company (NYSE:CPB). Moreover, Barclays Public Limited Co has 0.01% invested in Campbell Soup Company (NYSE:CPB) for 235,106 shares. Amica Mutual Insur has 14,928 shares. First Republic Inv Mgmt Inc reported 16,380 shares. Retirement Of Alabama accumulated 94,101 shares or 0.02% of the stock. Paloma Ptnrs Mngmt holds 0.05% of its portfolio in Campbell Soup Company (NYSE:CPB) for 82,700 shares. Swiss Bancshares, a Switzerland-based fund reported 1.13 million shares.

Since October 6, 2017, it had 0 insider buys, and 2 sales for $420,021 activity. $312,975 worth of stock was sold by Carolan Edward on Wednesday, December 20. PERRIN CHARLES R had sold 2,304 shares worth $107,046 on Friday, October 6.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: